Rocket


Overview
Financials
News + Filings

 
 

Keros Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18
Revenues10.010.0
            Revenue growth0.0% 
Cost of goods sold17.410.1
Gross profit-7.4-0.1
            Gross margin-73.8%-1.1%
General and administrative3.21.6
EBIT-10.6-1.7
            EBIT margin-105.6%-16.9%
Pre-tax income-12.3-1.1
Income taxes0.00.3
            Tax rate0.0% 
Net income-12.3-1.3
            Net margin-123.4%-13.4%
 
Diluted EPS$0.00($0.28)
Shares outstanding (diluted)5,050.04.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy